These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16122148)

  • 1. Applicability of recently established reference values for serum insulin-like growth factor 1: A comparison of two assays--an (automated) chemiluminescence immunoassay and an enzyme-linked immunosorbent assay.
    Ivan D; Brabant G; Kann PH;
    Clin Lab; 2005; 51(7-8):381-7. PubMed ID: 16122148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum insulin-like growth factor-I measurement in the follow-up of treated acromegaly: comparison of four immunoassays.
    Massart C; Poirier JY
    Clin Chim Acta; 2006 Nov; 373(1-2):176-9. PubMed ID: 16815351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum IGF-I measured by four different immunoassays in patients with adult GH deficiency or acromegaly and in a control population.
    Granada ML; Ulied A; Casanueva FF; Pico A; Lucas T; Torres E; Sanmartí A
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):942-50. PubMed ID: 17980002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of insulin-like growth factor-I and insulin-like growth factor-I binding protein-3: quality control for studies of stored serum.
    Berrigan D; Potischman N; Dodd KW; Nicar M; McQuillan G; Lavigne JA; Barrett JC; Ballard-Barbash R
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1017-22. PubMed ID: 17507631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical usefulness of a new chemiluminescent two-site immunoassay for human calcitonin.
    Grauer A; Raue F; Ziegler R
    Exp Clin Endocrinol Diabetes; 1998; 106(4):353-9. PubMed ID: 9792470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-3 measured by the IMMULITE automated chemiluminescence assay system in different blood specimens.
    Elmlinger MW; Zwirner M; Kühnel W
    Clin Lab; 2005; 51(3-4):145-52. PubMed ID: 15819169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal reference range of serum insulin-like growth factor (IGF)-I in healthy Thai adults.
    Plengpanich W; Mangkala J; Buranasukajorn P; Boonruang K; Sunthornyothin S; Suwanwalaikorn S; Khovidhunkit W; Sridama V; Snabboon T
    J Med Assoc Thai; 2008 Nov; 91(11):1681-4. PubMed ID: 19127789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study.
    Brabant G; von zur Mühlen A; Wüster C; Ranke MB; Kratzsch J; Kiess W; Ketelslegers JM; Wilhelmsen L; Hulthén L; Saller B; Mattsson A; Wilde J; Schemer R; Kann P;
    Horm Res; 2003; 60(2):53-60. PubMed ID: 12876414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reference ranges of serum IGF-1 and IGFBP-3 levels in a general adult population: results of the Study of Health in Pomerania (SHIP).
    Friedrich N; Alte D; Völzke H; Spilcke-Liss E; Lüdemann J; Lerch MM; Kohlmann T; Nauck M; Wallaschofski H
    Growth Horm IGF Res; 2008 Jun; 18(3):228-37. PubMed ID: 17997337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and laboratory evaluation of a new specific ELISA for intact proinsulin.
    Pfützner A; Pfützner AH; Kann PH; Stute R; Löbig M; Yang JW; Mistry J; Forst T
    Clin Lab; 2005; 51(5-6):243-9. PubMed ID: 15991797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults.
    Mattsson A; Svensson D; Schuett B; Osterziel KJ; Ranke MB
    Growth Horm IGF Res; 2008 Dec; 18(6):506-16. PubMed ID: 18550406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reference values for serum levels of insulin-like growth factor (IGF-1) and IGF-binding protein 3 (IGFBP-3) and their ratio in Chinese adolescents.
    Kong AP; Wong GW; Choi KC; Ho CS; Chan MH; Lam CW; Tong PC; Ozaki R; So WY; Ma RC; Lau JT; Chan JC
    Clin Biochem; 2007 Oct; 40(15):1093-9. PubMed ID: 17673197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of serum insulin-like growth factor-I reference values for the automated chemiluminescent Liaison® assay. Clinical utility in the follow-up of patients with treated acromegaly.
    Massart C; Poirier JY
    Clin Chim Acta; 2011 Jan; 412(3-4):398-9. PubMed ID: 21059350
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of a new fully automated one-step C-peptide chemiluminescence assay (LIAISON C-Peptid).
    Pfützner A; Löbig M; Fortunato A; Forst T
    Clin Lab; 2003; 49(5-6):227-32. PubMed ID: 15285178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specimen processing time and measurement of total insulin-like growth factor-I (IGF-I), free IGF-I, and IGF binding protein-3 (IGFBP-3).
    Harris TG; Strickler HD; Yu H; Pollak MN; Monrad ES; Travin MI; Xue X; Rohan TE; Kaplan RC
    Growth Horm IGF Res; 2006 Apr; 16(2):86-92. PubMed ID: 16530441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum insulin-like growth factor-I (IGF-I) reference ranges for chemiluminescence assay in childhood and adolescence. Data from a population of in- and out-patients.
    Bedogni G; Giannone G; Maghnie M; Giacomozzi C; Di Iorgi N; Pedicelli S; Peschiaroli E; Melioli G; Muraca M; Cappa M; Cianfarani S
    Growth Horm IGF Res; 2012; 22(3-4):134-8. PubMed ID: 22583946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoassays for the measurement of IGF-II, IGFBP-2 and -3, and ICTP as indirect biomarkers of recombinant human growth hormone misuse in sport. Values in selected population of athletes.
    Abellan R; Ventura R; Palmi I; di Carlo S; Bacosi A; Bellver M; Olive R; Pascual JA; Pacifici R; Segura J; Zuccaro P; Pichini S
    J Pharm Biomed Anal; 2008 Nov; 48(3):844-52. PubMed ID: 18617352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pitfalls of immunoassay and sample for IGF-I: comparison of different assay methodologies using various fresh and stored serum samples.
    Khosravi J; Diamandi A; Bodani U; Khaja N; Krishna RG
    Clin Biochem; 2005 Jul; 38(7):659-66. PubMed ID: 15885685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of an automated method for the quantification of von Willebrand factor antigen. Its application in the study of vascular dysfunction.
    Villa P; Iborra J; Serra J; Gilsanz A; Casaña P; Aznar JA; Aznar J
    Haematologica; 2001 Nov; 86(11):1180-5. PubMed ID: 11694404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management and interpretation of heterogeneous observational data: using insulin-like growth factor-I data from the NordiNet® International Outcome Study.
    Blankenstein O; Pedersen BT; Schlumpf M; Andreasen AH; Júlíusson PB
    Growth Horm IGF Res; 2015 Feb; 25(1):41-6. PubMed ID: 25542446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.